UNITED BIOMEDICAL INC purchased 0.0% of their position (22.91K shares) of VAXXINITY, INC. on the open market
Open‑market purchase worth $79.7K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 4/28/2022ACC: 0000899243-22-015866
+22.91K
Net shares
Net buyer
$79.7K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
22.91K acquired
Non-Derivative Transactions2
Class A common stock
Direct
Shares
+18.11K
Price / share
$3.45
Trade value
$62.47K
% of position
0.0%
4/26/2022
51.59M→51.61M
Class A common stock
Direct
Shares
+4.81K
Price / share
$3.58
Trade value
$17.22K
% of position
0.0%
4/27/2022
51.61M→51.62M
Total
Net shares
+22.91K
Net value
$79.69K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A common stock Direct | 4/26/2022 | P · Purchase | +18.11K | $3.45 | $62.47K | 0.0% | 51.59M | 51.61M |
| Class A common stock Direct | 4/27/2022 | P · Purchase | +4.81K | $3.58 | $17.22K | 0.0% | 51.61M | 51.62M |
| Total | +22.91K | $79.69K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Class A common stock
IndirectShares owned4.21M
Total
4.21M indirect4.21M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A common stock | 4.21M | Indirect |
| Total | 4.21M | 4.21M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported